Bayer unveils non-hormonal menopause treatment at 2026 World Congress

Bayer presented a new non-hormonal treatment for vasomotor symptoms of menopause at the 2026 World Congress on the Menopause, offering an alternative for women who cannot or choose not to use estrogen therapy. The treatment's regulatory timeline and market availability remain uncertain. This could expand therapeutic options in a growing women's health market.